Logo image of LMAT

LEMAITRE VASCULAR INC (LMAT) Stock Overview

NASDAQ:LMAT - US5255582018 - Common Stock

95.365 USD
+0.09 (+0.1%)
Last: 8/29/2025, 8:00:00 PM
95.365 USD
0 (0%)
After Hours: 8/29/2025, 8:00:00 PM

LMAT Key Statistics, Chart & Performance

Key Statistics
52 Week High109.58
52 Week Low71.42
Market Cap2.16B
Shares22.64M
Float20.81M
Yearly Dividend0.64
Dividend Yield0.84%
EPS(TTM)2.06
PE46.29
Fwd PE37.62
Earnings (Next)10-29 2025-10-29/amc
IPO10-19 2006-10-19
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


LMAT short term performance overview.The bars show the price performance of LMAT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10 15

LMAT long term performance overview.The bars show the price performance of LMAT in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80

The current stock price of LMAT is 95.365 USD. In the past month the price increased by 17.68%. In the past year, price increased by 5.62%.

LEMAITRE VASCULAR INC / LMAT Daily stock chart

LMAT Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.07 230.89B
ISRG INTUITIVE SURGICAL INC 58.79 169.67B
BSX BOSTON SCIENTIFIC CORP 37.28 156.32B
SYK STRYKER CORP 30.46 149.64B
MDT MEDTRONIC PLC 16.78 119.05B
BDX BECTON DICKINSON AND CO 13.52 55.31B
IDXX IDEXX LABORATORIES INC 53.88 51.77B
EW EDWARDS LIFESCIENCES CORP 31.65 47.75B
RMD RESMED INC 28.74 40.19B
GEHC GE HEALTHCARE TECHNOLOGY 15.82 33.66B
DXCM DEXCOM INC 44.32 29.55B
PHG KONINKLIJKE PHILIPS NVR- NY 16.42 26.56B

About LMAT

Company Profile

LMAT logo image LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company is headquartered in Burlington, Massachusetts and currently employs 651 full-time employees. The company went IPO on 2006-10-19. The firm develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. The company also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.

Company Info

LEMAITRE VASCULAR INC

63 2nd Ave

Burlington MASSACHUSETTS 01803 US

CEO: George W. LeMaitre

Employees: 658

LMAT Company Website

LMAT Investor Relations

Phone: 17812212266

LEMAITRE VASCULAR INC / LMAT FAQ

What is the stock price of LEMAITRE VASCULAR INC today?

The current stock price of LMAT is 95.365 USD. The price increased by 0.1% in the last trading session.


What is the ticker symbol for LEMAITRE VASCULAR INC stock?

The exchange symbol of LEMAITRE VASCULAR INC is LMAT and it is listed on the Nasdaq exchange.


On which exchange is LMAT stock listed?

LMAT stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for LEMAITRE VASCULAR INC stock?

17 analysts have analysed LMAT and the average price target is 106.87 USD. This implies a price increase of 12.07% is expected in the next year compared to the current price of 95.365. Check the LEMAITRE VASCULAR INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is LEMAITRE VASCULAR INC worth?

LEMAITRE VASCULAR INC (LMAT) has a market capitalization of 2.16B USD. This makes LMAT a Mid Cap stock.


How many employees does LEMAITRE VASCULAR INC have?

LEMAITRE VASCULAR INC (LMAT) currently has 658 employees.


What are the support and resistance levels for LEMAITRE VASCULAR INC (LMAT) stock?

LEMAITRE VASCULAR INC (LMAT) has a support level at 95.36 and a resistance level at 100.12. Check the full technical report for a detailed analysis of LMAT support and resistance levels.


Is LEMAITRE VASCULAR INC (LMAT) expected to grow?

The Revenue of LEMAITRE VASCULAR INC (LMAT) is expected to grow by 13.91% in the next year. Check the estimates tab for more information on the LMAT EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy LEMAITRE VASCULAR INC (LMAT) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does LEMAITRE VASCULAR INC (LMAT) stock pay dividends?

LEMAITRE VASCULAR INC (LMAT) has a dividend yield of 0.84%. The yearly dividend amount is currently 0.64. Check the full fundamental report for a detailed analysis of LMAT dividend history, reliability and sustainability.


When does LEMAITRE VASCULAR INC (LMAT) report earnings?

LEMAITRE VASCULAR INC (LMAT) will report earnings on 2025-10-29, after the market close.


What is the Price/Earnings (PE) ratio of LEMAITRE VASCULAR INC (LMAT)?

The PE ratio for LEMAITRE VASCULAR INC (LMAT) is 46.29. This is based on the reported non-GAAP earnings per share of 2.06 and the current share price of 95.365 USD. Check the full fundamental report for a full analysis of the valuation metrics for LMAT.


What is the Short Interest ratio of LEMAITRE VASCULAR INC (LMAT) stock?

The outstanding short interest for LEMAITRE VASCULAR INC (LMAT) is 6.44% of its float. Check the ownership tab for more information on the LMAT short interest.


LMAT Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to LMAT. When comparing the yearly performance of all stocks, LMAT turns out to be only a medium performer in the overall market: it outperformed 67.69% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

LMAT Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to LMAT. LMAT gets an excellent profitability rating and is at the same time showing great financial health properties.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LMAT Financial Highlights

Over the last trailing twelve months LMAT reported a non-GAAP Earnings per Share(EPS) of 2.06. The EPS increased by 23.35% compared to the year before.


Industry RankSector Rank
PM (TTM) 20.08%
ROA 8.16%
ROE 12.99%
Debt/Equity 0.46
Chartmill High Growth Momentum
EPS Q2Q%15.38%
Sales Q2Q%15.01%
EPS 1Y (TTM)23.35%
Revenue 1Y (TTM)14.11%

LMAT Forecast & Estimates

17 analysts have analysed LMAT and the average price target is 106.87 USD. This implies a price increase of 12.07% is expected in the next year compared to the current price of 95.365.

For the next year, analysts expect an EPS growth of 20.02% and a revenue growth 13.91% for LMAT


Analysts
Analysts76.47
Price Target106.87 (12.06%)
EPS Next Y20.02%
Revenue Next Year13.91%

LMAT Ownership

Ownership
Inst Owners95.69%
Ins Owners8.54%
Short Float %6.44%
Short Ratio8.74